Jingjing Li

Efficacy and safety of anti-CD19 CAR T-cell therapy in 110 patients with B-cell acute lymphoblastic leukemia with high-risk features

Xian Zhang, Xin‐an Lu, Junfang Yang et al. · Blood Advances · 2020 · 206 citations · Full text

Hematological Malignancy, Cell Therapy, Tp53 Mutation +15

Angiopoietin-2 as a Biomarker and Target for Immune Checkpoint Therapy

Xinqi Wu, Anita Giobbie‐Hurder, Xiaoyun Liao et al. · Cancer Immunology Research · 2016 · 161 citations · Full text

Transient and Local Expression of Chemokine and Immune Checkpoint Traps To Treat Pancreatic Cancer

Lei Miao, Jingjing Li, Qi Liu et al. · ACS Nano · 2017 · 129 citations · Full text

Maturation and abundance of tertiary lymphoid structures are associated with the efficacy of neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer

Xiaoyan Sun, Weiran Liu, Leina Sun et al. · Journal for ImmunoTherapy of Cancer · 2022 · 123 citations · Full text

Next-day manufacture of a novel anti-CD19 CAR-T therapy for B-cell acute lymphoblastic leukemia: first-in-human clinical study

Junfang Yang, Jiaping He, Xian Zhang et al. · Blood Cancer Journal · 2022 · 90 citations · Full text